BY REGION The GLP-1 agonists market covers North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa
Pharmacy Compounding Advisory Committee Meeting Information Alliance for Pharmacy Compounding
For example, in a 2013 review on synthetic peptides that spans nearly 30 pages, we get only these statements on Selanks side effect profile:20 Selank has a prolonged effect and no side effects and, on the whole, is [efficiently delivered] in young and elderly monkeys. The action of Selank is not accompanied by undesirable characteristics (hypnosedation and myorelaxation) and side effects (amnesia, withdrawal, and dependence). According to the results of preclinical and clinical studies of Semax and Selank, it can be concluded that both peptides are safe and highly effective. That makes Selank look pretty good from a safety perspective, but the U.S
There are no established dosing protocols, treatment durations, or safety guidelines for human use
What are the emerging trends in this market and the reasons behind them
Theres also a scientific reason this makes sense